AstraZeneca used ‘outdated and potentially misleading data’ that overstated the effectiveness of its vaccine, independent panel says
The company and Oxford University had announced Monday that a clinical trial in the United States, Chile and Peru showed 79 percent efficacy.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news
More News: AstraZeneca | Chile Health | Clinical Trials | Health | Oxford University | Peru Health | USA Health | Vaccines